Jay Hagan, Managing Director
Amgen Ventures
Mr. Jay Hagan joined Amgen in 1998 and is currently the Managing Director
for Amgen Ventures, the Company’s corporate venture capital fund.
He oversees and directs the fund’s investment in early-stage
biotechnology companies focused on discovering and developing human therapeutics.
Hagan was previously director of Corporate Development at Amgen where
he had responsibility for M&A, as well as support of significant corporate
driven alliance initiatives. He has led a number of notable transactions
including the acquisitions of Tularik and Immunex as well as the sale
of the Novantrone business.
Before joining Amgen, Hagan worked for Genzyme where he was a biochemical
engineer.
Hagan received a Master’s in Business Administration from Northeastern
University and a B.S. in Physiology and Neuroscience from UC San
Diego.
